Raltegravir in the Swiss HIV Cohort Study

NCT00904644 · clinicaltrials.gov ↗

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Raltegravir

Sponsor

University of Zurich

Collaborators

[object Object]
[object Object]